2016
DOI: 10.1002/mawe.201600458
|View full text |Cite
|
Sign up to set email alerts
|

Antitumor effect of superparamagnetic iron oxide nanoparticles conjugated with doxorubicin during magnetic nanotherapy of Lewis Lung carcinoma

Abstract: Superparamagnetic Iron(II,III) oxide Fe 3 O 4 nanoparticles (NP) in magnetic nanocomplex (MNC2) with antitumor drug doxorubicin (DOXO) induced a greater antitumor and antimetastatic effect compared to the magnetic nanocomplex (MNC1) composed of ferromagnetic nanoparticles with DOXO and conventional DOXO during magnetic nanotherapy of animals with Lewis lung carcinoma. The intratumor temperature did not exceed 39°C. MNC2 had g-factors of 2.00, 2.30 and 4.00. MNC1 had the g-factor of 2.50. The MNC2 increased the… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

1
0
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
2
2
1

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(1 citation statement)
references
References 21 publications
1
0
0
Order By: Relevance
“…The decrease in tumor growth triggered by MNC2 comprising superparamagnetic NP and DOXO, which had a lower standard deviation of Gaussian distribution in the PL spectrum of conventional DOXO than MNC1 composed of ferromagnetic NP, could have been caused by increased apoptosis or necrosis in tumor cells. These findings also support the results of earlier observations, in which MNC2 showed a more pronounced antitumor effect than MNC1 in a mouse model of Lewis lung carcinoma [70].…”
Section: Discussionsupporting
confidence: 92%
“…The decrease in tumor growth triggered by MNC2 comprising superparamagnetic NP and DOXO, which had a lower standard deviation of Gaussian distribution in the PL spectrum of conventional DOXO than MNC1 composed of ferromagnetic NP, could have been caused by increased apoptosis or necrosis in tumor cells. These findings also support the results of earlier observations, in which MNC2 showed a more pronounced antitumor effect than MNC1 in a mouse model of Lewis lung carcinoma [70].…”
Section: Discussionsupporting
confidence: 92%